A-87049

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameA-87049
Drug Alias NameA-87049
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSqualene synthase inhibitors
TargetsSqualene synthase
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A
Related LinksN/A